Antineoplastic Agents, Phytogenic
Leukemia P388
Amaryllidaceae Alkaloids
Ellipticines
Doxorubicin
Drug Screening Assays, Antitumor
Antibiotics, Antineoplastic
Bryostatins
Antineoplastic Agents, Alkylating
A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026)
Ancitabine
Neoplasms
Gallium
Depsipeptides
Tumor Cells, Cultured
Cisplatin
An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.
Paclitaxel
6-Mercaptopurine
Apoptosis
One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.
Aminoacridines
Epothilones
Cell Survival
Molecular Structure
Lactones
Daunorubicin
Fluorouracil
Bleomycin
Dose-Response Relationship, Drug
Etoposide
A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.
Antineoplastic Combined Chemotherapy Protocols
Drug Resistance, Neoplasm
Prodrugs
Drug Evaluation, Preclinical
Drug Evaluation
Cell Division
Xenograft Model Antitumor Assays
Drug Resistance
Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.
Macrolides
Neoplasms, Experimental
Methotrexate
Camptothecin
Cell Cycle
The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE.
Mice, Nude
HL-60 Cells
A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. (From Hay et al., American Type Culture Collection, 7th ed, pp127-8)
Enzyme Inhibitors
Drug Administration Schedule
Isoquinolines
Neoplasm Transplantation
Biotransformation
The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
Drug Interactions
DNA Damage
Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS.
Cyclophosphamide
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.
Stereoisomerism
Clinical Trials as Topic
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
Leukemia
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
Ovarian Neoplasms
Caspases
A family of intracellular CYSTEINE ENDOPEPTIDASES that play a role in regulating INFLAMMATION and APOPTOSIS. They specifically cleave peptides at a CYSTEINE amino acid that follows an ASPARTIC ACID residue. Caspases are activated by proteolytic cleavage of a precursor form to yield large and small subunits that form the enzyme. Since the cleavage site within precursors matches the specificity of caspases, sequential activation of precursors by activated caspases can occur.
Taxoids
Structure-Activity Relationship
DNA
A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
Phospholipid Ethers
Phospholipids which have an alcohol moiety in ethereal linkage with a saturated or unsaturated aliphatic alcohol. They are usually derivatives of phosphoglycerols or phosphatidates. The other two alcohol groups of the glycerol backbone are usually in ester linkage. These compounds are widely distributed in animal tissues.
RNA, Messenger
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Reactive Oxygen Species
Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of signal transduction and gene expression, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS.
Cells, Cultured
Gloves, Protective
Coverings for the hands, usually with separations for the fingers, made of various materials, for protection against infections, toxic substances, extremes of hot and cold, radiations, water immersion, etc. The gloves may be worn by patients, care givers, housewives, laboratory and industrial workers, police, etc.
Aster Plant
Occupational Exposure
Treatment Outcome
Medical Secretaries
Oncology Nursing
Sulindac
A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects.
Protective Devices
Protective Clothing
Equipment Contamination
Amsacrine
Decontamination
Phlebitis
Environmental Monitoring
Hazardous Substances
Inhibitory Concentration 50
Carcinoma, Ehrlich Tumor
Floxuridine
An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Drug Compounding
2-Propanol
Tumor Stem Cell Assay
Carmustine
A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
Cytarabine
A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)
Topoisomerase II Inhibitors
Drug Resistance, Multiple
Farnesyltranstransferase
Oncology Service, Hospital
Comet Assay
A genotoxicological technique for measuring DNA damage in an individual cell using single-cell gel electrophoresis. Cell DNA fragments assume a "comet with tail" formation on electrophoresis and are detected with an image analysis system. Alkaline assay conditions facilitate sensitive detection of single-strand damage.
Drugs, Investigational
Isocoumarins
Nitrogen Mustard Compounds
Nurses
Suramin
A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
Alkaloids
Plant Extracts
Mitomycin
Azacitidine
DNA Adducts
DNA Topoisomerases, Type II
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions.They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
Pharmacists
Lethal Dose 50
Gene Expression Regulation, Neoplastic
Mutagenicity Tests
Metabolic Detoxication, Drug
HT29 Cells
Blotting, Western
Hydrazones
Alkylating Agents
Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases.
Mammary Neoplasms, Experimental
Organoplatinum Compounds
Octreotide
Glutathione Transferase
Mitomycins
Dehydroascorbic Acid
Anthracyclines
Electronic volume analysis of L1210 chemotherapy. (1/35913)
The rapid analysis of in vivo chemotherapy on the L1210 ascites tumor grown in C57BL/6 X DBA/2F1 mice has been shown by means of an electronic volume analysis. The drugs were injected on the 4th day of tumor growth, and the cells in the peritoneal cavity were studied at 24-hr intervals on the 5th through 7th day. Using the electronic cell volume distributions, combined with labeling indices, cell morphology, and cell counts, it was found that the alkylating agents. 1,3-bis(2-chloroethyl)-1-nitrosourea and cyclophosphamide, at the dosages used, were more effective than the S-phase-specific drugs, palmitoyl ester of 1-beta-D-arabinofuranosylcytosine, vincristine, and methotrexate. (+info)Various forms of chemically induced liver injury and their detection by diagnostic procedures. (2/35913)
A large number of chemical agents, administered for therapeutic or diagnostic purposes, can produce various types of hepatic injury by several mechanisms. Some agents are intrinsically hepatotoxic, and others produce hepatic injury only in the rare, uniquely susceptible individual. Idiosyncrasy of the host is the mechanism for most types of drug-induced hepatic injury. It may reflect allergy to the drug or a metabolic aberation of the host permitting the accumulation of hepatotoxic metabolites. The syndromes of hepatic disease produced by drugs have been classified hepatocellular, hepatocanalicular, mixed and canalicular. Measurement of serum enzyme activities has provided a powerful tool for studies of hepatotoxicity. Their measurement requires awareness of relative specificity, knowledge of the mechanisms involved, and knowledge of the relationship between known hepatotoxic states and elevated enzyme activities. (+info)Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop. (3/35913)
The Mdm2 protein is frequently overexpressed in human non-seminomatous germ cell tumours and transitional carcinoma of the bladder where it may contribute to tolerance of wtp53. Mdm2 forms an autoregulatory feedback loop with p53; the Mdm2 gene is responsive to transactivation by p53 and once synthesized the Mdm2 protein terminates the p53 response. We show here that the topoisomerase poison etoposide, like ultra violet irradiation, inhibits Mdm2 synthesis. Cytotoxic concentrations of etoposide (IC90 for > 3 h) result in inhibition of Mdm2 induction at both the RNA and protein level. Rapid apoptosis ensues. Global transcription is not inhibited: p21waf-1/cip1 and GADD45 expression increase in a dose dependent manner. Inhibition of Mdm2 synthesis depends on the continuous presence of etoposide, suggesting the DNA damage may prevent transcription. Downregulation of Mdm2 transcript occurs in cells expressing HPV16-E6 suggesting that inhibition of Mdm2 transcription is p53-independent. When cells are -treated with a pulse (1 h) of etoposide and reincubated in drug free medium, Mdm2 synthesis commences immediately after damage is repaired (3 h) and the p53 response is attenuated. Induction of apoptosis and loss of clonogenicity are 3-5-fold lower under pulse treatment conditions. This is the first observation of inhibition of Mdm2 transcription following treatment with topoisomerase (topo II) poisons, a feature that may be useful in tumour types where p53 is tolerated by overexpression of Mdm2. (+info)Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient. (4/35913)
Primary blasts of a t(11;17)(q23;q21) acute promyelocytic leukaemia (APL) patient were analysed with respect to retinoic acid (RA) and arsenic trioxide (As2O3) sensitivity as well as PLZF/RARalpha status. Although RA induced partial monocytic differentiation ex vivo, but not in vivo, As203 failed to induce apoptosis in culture, contrasting with t(15;17) APL and arguing against the clinical use of As203 in t(11;17)(q23;q21) APL. Prior to cell culture, PLZF/RARalpha was found to exactly co-localize with PML onto PML nuclear bodies. However upon cell culture, it quickly shifted towards microspeckles, its localization found in transfection experiments. Arsenic trioxide, known to induce aggregation of PML nuclear bodies, left the microspeckled PLZF/RARalpha localization completely unaffected. RA treatment led to PLZF/RARalpha degradation. However, this complete PLZF/RARalpha degradation was not accompanied by differentiation or apoptosis, which could suggest a contribution of the reciprocal RARalpha/PLZF fusion product in leukaemogenesis or the existence of irreversible changes induced by the chimera. (+info)Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. (5/35913)
Interleukin 6 (IL-6) is the major survival factor for myeloma tumor cells and induces signaling through the STAT proteins. We report that one STAT family member, Stat3, is constitutively activated in bone marrow mononuclear cells from patients with multiple myeloma and in the IL-6-dependent human myeloma cell line U266. Moreover, U266 cells are inherently resistant to Fas-mediated apoptosis and express high levels of the antiapoptotic protein Bcl-xL. Blocking IL-6 receptor signaling from Janus kinases to the Stat3 protein inhibits Bcl-xL expression and induces apoptosis, demonstrating that Stat3 signaling is essential for the survival of myeloma tumor cells. These findings provide evidence that constitutively activated Stat3 signaling contributes to the pathogenesis of multiple myeloma by preventing apoptosis. (+info)Overexpression of the multidrug resistance-associated protein (MRP1) in human heavy metal-selected tumor cells. (6/35913)
Cellular and molecular mechanisms involved in the resistance to cytotoxic heavy metals remain largely to be characterized in mammalian cells. To this end, we have analyzed a metal-resistant variant of the human lung cancer GLC4 cell line that we have selected by a step-wise procedure in potassium antimony tartrate. Antimony-selected cells, termed GLC4/Sb30 cells, poorly accumulated antimony through an enhanced cellular efflux of metal, thus suggesting up-regulation of a membrane export system in these cells. Indeed, GLC4/Sb30 cells were found to display a functional overexpression of the multidrug resistance-associated protein MRP1, a drug export pump, as demonstrated by Western blotting, reverse transcriptase-polymerase chain reaction and calcein accumulation assays. Moreover, MK571, a potent inhibitor of MRP1 activity, was found to markedly down-modulate resistance of GLC4/Sb30 cells to antimony and to decrease cellular export of the metal. Taken together, our data support the conclusion that overexpression of functional MRP1 likely represents one major mechanism by which human cells can escape the cytotoxic effects of heavy metals. (+info)Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results. (7/35913)
Fourteen patients with metastatic pancreatic adenocarcinoma were treated with the long-acting somatostatin (SST) analogue lanreotide. No objective response was obtained, and the median survival was 4 months (range 1.8-7 months). Pancreatic cancer could not be visualized by means of SST-receptor (R) scintigraphy in our patients. In vitro data also demonstrated absence of SSTR2 expression, suggesting pancreatic cancer not to be a potential target for treatment with SST analogues. (+info)Role of dexamethasone dosage in combination with 5-HT3 antagonists for prophylaxis of acute chemotherapy-induced nausea and vomiting. (8/35913)
Dexamethasone (20 mg) or its equivalent in combination with 5-HT3 antagonists appears to be the gold-standard dose for antiemetic prophylaxis. Additional to concerns about the use of corticosteroids with respect to enhanced tumour growth or impaired killing of the tumour cells, there is evidence that high-dosage dexamethasone impairs the control of delayed nausea and emesis, whereas lower doses appear more beneficial. To come closer to the most adequate dose, we started a prospective, single-blind, randomized trial investigating additional dosage of 8 or 20 mg dexamethasone to tropisetron (Navoban), a 5-HT3 receptor antagonist, in cis-platinum-containing chemotherapy. After an interim analysis of 121 courses of chemotherapy in 69 patients, we have been unable to detect major differences between both treatment alternatives. High-dose dexamethasone (20 mg) had no advantage over medium-dose dexamethasone with respect to objective and subjective parameters of acute and delayed nausea and vomiting. In relation to concerns about the use of corticosteroids in non-haematological cancer chemotherapy, we suggest that 8 mg or its equivalent should be used in combination with 5-HT3 antagonists until further research proves otherwise. (+info)
Docetaxel is used seeing that an effective chemotherapeutic agent in breasts - PARP Inhibitors in Ovarian and Other Cancers
Improvement in advanced pancreatic cancer survival with novel chemotherapeutic strategies - experience of a community based...
A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer<...
Manageable Toxicity, Promising Antitumor Activity With Pembrolizumab for Gastric Cancer - Cancer Therapy Advisor
Vascularization, oxygenation, and metabolism in colorectal cancer : implications for cytotoxic treatment
Insulin receptor substrate 1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death.
2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition<...
Cancers | Free Full-Text | Genetic Interactions of STAT3 and Anticancer Drug Development
Cancers | Free Full-Text | Genetic Interactions of STAT3 and Anticancer Drug Development | HTML
New cancer drug Ibrutinib boosts survival rate to 90% | Daily Mail Online
Study shows ibrutinib superior to traditional chemotherapy in untreated chronic leukemia patients | EurekAlert! Science News
New Anti-Cancer Medications
Statins Toxic Side Effects: Evidence from 500 scientific papers (Cholesterol) - Free eBooks Download
Cell death mystery yields new suspect for cancer drug development - News Room - UNC Health Care
Plus it
Plus it
PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations<...
Uncharted Waters: The Making of a New Cancer Drug | Memorial Sloan Kettering Cancer Center
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017
Anticancer Drugs | Cancer Symptoms, Cancer Drugs Cheap Price in USA
Anticancer Drugs | Cancer Symptoms, Cancer Drugs Cheap Price in USA
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of...
Chemotherapy-induced peripheral neuropathy - Wikipedia
ASCO Releases Guideline on Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult...
Inhibition of mTOR kinase by AZD8055 can antagonize chemotherapy-induced cell death through autophagy induction and down...
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. |...
Chemotherapy-induced peripheral neuropathy: the end of the beginning? | Journal of Neurology, Neurosurgery & Psychiatry
6BA5 | POTENT AND SELECTIVE ANTITUMOR ACTIVITY OF A T-CELL ENGAGING BISPECIFIC ANTIBODY TARGETING A MEMBRANE-PROXIMAL EPITOPE...
A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients - Full...
erbB-2 Signaling Enhances Cisplatin-induced Cytotoxicity in Human Breast Carcinoma Cells: Association between an Oncogenic...
Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of...
ENMD-2076 Demonstrates Preclinical Antitumor Activity in Colorectal Cancer
Development and characterization of pro-apoptotic drug candidates for anticancer drug discovery
The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From...
Evaluating novel chemotherapeutic strategies in colorectal and gastric cancer: the role of histone deacetylase inhibitors and...
Smoke and Mirrors: Natural Cancer Bullets A - Z
New Anti-Cancer Therapy That Promoted Cancer Cells to Suicide by Inducing Cell Apoptosis Was Found by Albert Einstein College...
Chemotherapy-induced peripheral neuropathy | Peter MacCallum Cancer Centre
A combined model of human erythropoiesis and granulopoiesis under growth factor and chemotherapy treatment | Theoretical...
JCI -
Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of...
JCI -
Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of...
lGnRH-III - a Promising Candidate for Anticancer Drug Development
Enhanced efficacy in drug-resistant cancer cells through synergistic nanoparticle mediated delivery of cisplatin and decitabine...
E2F1 drives chemotherapeutic drug resistance via ABCG2 - Enlighten: Publications
Christia vespertilionis plant extracts as novel antiproliferative agent against human neuroendocrine tumor cells
Plus it
Plus it
Curcumin, a promising anti-cancer therapeutic: a review of its chemical properties, bioactivity and approaches to cancer cell...
Recherche uO Research: A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast...
The mechanisms underlying the proapoptotic effect of the chemotherapeutic agent, cisplatin, | Pharmacokinetic interaction of...
A Dynamic De-Escalating Dosing Strategy to Determine the Optimal Biological Dose for Antiangiogenic Drugs | Clinical Cancer...
Synthesis and Cytotoxic Evaluation of Some Novel Sulfonamide Derivatives Against a Few Human Cancer Cells
Continuing challenges and current issues in acute lymphoblastic leukemia<...
Targeted siRNA Delivery - EnGeneIC
Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy - Semantic Scholar
Evaluation of mitochondria in mouse oocytes following cisplatin exposure - DOAJ
Development and validation of method for TH588 and TH287, potent MTH1 inhibitors and new anti-cancer agents, for...
Synthesis and evaluation of Taxol-folic acid conjugates as targeted antineoplastics<...
Warburgs Lens: A Mathematical oncology pre-print discussion forum: July 2014
Warburgs Lens: A Mathematical oncology pre-print discussion forum: July 2014
Growth curve (biology) - Wikipedia
NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis
- Mayo Clinic
Plus it
Amgen cancels study on pancreatic cancer drug - College News
JAIRO | 検索結果一覧
IDEALS @ Illinois: Strategies for the Selective Treatment of Cancer, Including the Identification and Mechanism of Action of...
Streptomyces griseoluteus
"Antineoplastic agents. 47. Structure of an antineoplastic agent from Streptomyces griseoluteus". Journal of the American ...
John Hooper (marine biologist)
"Antineoplastic agents. 219. Isolation and structure of the cell growth inhibitory constituents from the western Pacific marine ... "Antineoplastic agents. 257. Isolation and structure of spongistatin 1". Journal of Organic Chemistry. 58 (6): 1302-1304. doi: ...
Narcissus (plant)
The bulbs of N. poeticus contain the antineoplastic agent narciclasine. This usage is also found in later Arabian, North ... Pettit, GR; Cragg, GM; Singh, SB; Duke, JA; Doubek, DL (1990). "Antineoplastic agents, 162. Zephyranthes candida". Journal of ... "Antineoplastic Agents. 587. Isolation and Structure of 3-Epipancratistatin from Narcissus cv. Ice Follies". Journal of Natural ... as Potential Anticancer Agents". Journal of Medicinal Chemistry. 52 (4): 1100-1114. doi:10.1021/jm8013585. PMID 19199649. ...
Psymberin
Pettit GR, Xu JP, Chapuis JC, Pettit RK, Tackett LP, Doubek DL, Hooper JN, Schmidt JM (2004). "Antineoplastic agents. 520. ...
Amaryllis
Pettit, G. R.; Gaddamidi, V.; Goswami, A.; Cragg, G. M. (1984). "Antineoplastic agents,99. Amaryllis beladonna". Journal of ...
Aplidium californicum
Certain antineoplastic agents, bryostatins 4 and 5, have been extracted from Aplidium californicum and are being evaluated. ... Pettit GR, Leet JE, Herald CL, Kamano Y, Doubek DL (1986). "Antineoplastic agents, 116. An evaluation of the marine ascidian ...
Combretum caffrum
CS1 maint: discouraged parameter (link) Pettit GR, Cragg GM, Singh SB (May-June 1987). "Antineoplastic agents, 122. ...
Prednisone
"Antineoplastic Agents, Hormonal". Medical Subject Headings. U.S. National Library of Medicine. 2009. Retrieved 11 November 2010 ...
Bromoketoprogesterone
ISBN 978-3-642-99941-3. Alan C. Sartorelli; David G. Johns (27 November 2013). Antineoplastic and Immunosuppressive Agents. ... Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. Halogenated ... Carpenter JT (1988). "Progestational agents in the treatment of breast cancer". Cancer Treat. Res. Cancer Treatment and ...
Estrogen (medication)
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. Nathanson ... 549-. ISBN 978-3-642-30725-6. The first sex steroid used as pharmacological agent was Progynon, first sold by Schering AG in ...
Allenolic acid
Sartorelli AC, Johns DG (27 November 2013). Antineoplastic and Immunosuppressive Agents. Springer Science & Business Media. pp ...
Estriol
31-. ISBN 978-1-4613-2157-6. Sartorelli AC, Johns DG (27 November 2013). Antineoplastic and Immunosuppressive Agents. Springer ...
Dimethylstilbestrol
83-. ISBN 978-1-4832-7299-3. Alan C. Sartorelli; David G. Johns (27 November 2013). Antineoplastic and Immunosuppressive Agents ...
Anthramycin
Sartorelli, Alan C.; Johns, David G. (27 November 2013). Antineoplastic and Immunosuppressive Agents. Springer Science & ... Anthramycin is an active anti-tumor agent and antibiotic. It works by inhibiting the synthesis of RNA and DNA of carcinoma ...
Hydroxyprogesterone caproate
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. Crowley, ... Geller J, Fruchtman B, Newman H, Roberts T, Silva R (February 1967). "Effect of progestational agents on carcinoma of the ... Hall NR (June 2011). "What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?". Obstetrics ... In the group of new parenteral progestational agents, three substances developed by Karl Junkmann1,2 are the most outstanding ...
Oxofluoxymesterone
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. ...
Fluorometholone acetate
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. Oxylone ... ISBN 978-3-88763-075-1. Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and ...
Androstanolone
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. Council on ... However, androstanolone is nonetheless described as a very poor anabolic agent. This is attributed to its high affinity as a ... von Deutsch DA, Abukhalaf IK, Lapu-Bula R (15 October 2003). "Anabolic Doping Agents". In Mozayani A, Raymon L (eds.). Handbook ... 63-. ISBN 978-3-88763-075-1. Morton I, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and ...
Doisynolic acid
ISBN 978-0-323-13916-8. Alan C. Sartorelli; David G. Johns (27 November 2013). Antineoplastic and Immunosuppressive Agents. ...
Androstenediol diacetate
Antineoplastic and Immunosuppressive Agents. pp. 170-192. doi:10.1007/978-3-642-65806-8_11. ISBN 978-3-642-65806-8. v t e v t e ...
Estriol (medication)
31-. ISBN 978-1-4613-2157-6. Alan C. Sartorelli; David G. Johns (27 November 2013). Antineoplastic and Immunosuppressive Agents ... I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer ...
1-Deoxysphingolipids
It has the role of antineoplastic agent, which means it can inhibit or prevent the neoplasms' proliferation. It is also the ... "antineoplastic agent (CHEBI:35610)". www.ebi.ac.uk. Retrieved 2019-10-26. "1-deoxysphinganine". Avanti Polar Lipids. Retrieved ...
List of sex-hormonal aqueous suspensions
Antineoplastic and Immunosuppressive Agents. Springer Science & Business Media. pp. 181-. ISBN 978-3-642-65806-8. Heinrich Kahr ...
Chemotherapy
Available agents[edit]. Main article: List of antineoplastic agents. There is an extensive list of antineoplastic agents. ... Alkylating agents[edit]. Main article: Alkylating antineoplastic agent. Alkylating agents are the oldest group of ... The increased use of antineoplastic agents in veterinary oncology also puts these workers at risk for exposure to these drugs.[ ... Antineoplastic Agents in Encyclopedia of Molecular Pharmacology, 2nd Edition, Volume 1. Eds. Offermanns S and Rosenthal W. ...
O6-Benzylguanine
It is an antineoplastic agent. It exerts its effect by acting as a suicide inhibitor of the enzyme O6-alkylguanine-DNA ... O6-BG was used clinically in combination with the alkylating agent temozolomide for glioblastoma, however the combination was ...
Alestramustine
Milne GW (1 July 2000). Ashgate Handbook of Antineoplastic Agents. Wiley. p. 5. ISBN 978-0-566-08382-2. Tripathi KD (30 ... List of hormonal cytostatic antineoplastic agents List of estrogen esters § Estradiol esters NCI Thesaurus. "Alestramustine". ... is a cytostatic antineoplastic agent which was never marketed. It is the L-alanine ester of estramustine, which is a ...
EPOCH (chemotherapy)
... an alkylating antineoplastic agent; Hydroxydaunorubicin, also known as doxorubicin: an anthracycline antibiotic that is able to ...
Alacizumab pegol
... is an antineoplastic agent. Chemically, it is a pegylated F(ab')2 fragment of a monoclonal antibody. ...
Streptomyces ardus
Antineoplastic and Immunosuppressive Agents part 2. Springer Science & Business Media. ISBN 978-3-642-65806-8. Hatano, K. (2003 ...
Rituximab
Targeted cancer therapy / antineoplastic agents (L01). CI monoclonal antibodies ("-mab"). Receptor tyrosine kinase. *ErbB: HER1 ... ocrelizumab, humanized (90%-95% human) B cell-depleting agent.. *ofatumumab (HuMax-CD20) a fully human B cell-depleting agent.[ ... The use of rituximab has not been proven to be efficacious in this setting and like all depleting agents, carries with it the ...
Afatinib
Targeted cancer therapy / antineoplastic agents (L01). CI monoclonal antibodies ("-mab"). Receptor tyrosine kinase. *ErbB: HER1 ... BIBW 2992 Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following BIBW 2992 Monotherapy in ...
Acolbifene
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.. *v ... List of investigational hormonal agents § Estrogenics. References[edit]. *^ Gauthier, S; Cloutier, J; Dory, YL; Favre, A; ...
Acute inhalation injury
... followed by death allowing for evaluation of novel cytoprotective agents. Potential tissue reparative agents can be evaluated ... Bleomycin is an antineoplastic antibiotic drug isolated in 1966 from the actinomycete Streptomyces verticillus. Bleomycin forms ... Other inhaled agents may be directly toxic (e.g. cyanide, carbon monoxide), or cause harm simply by displacing oxygen and ... These agents are less likely to produce early warning signs (phosgene in low concentrations has a pleasant odor), are more ...
Gonadotropin-releasing hormone agonist
The agents nafarelin and triptorelin are agonists with single substitutions at position 6. ... Cryptorchidism; Delayed puberty; Diagnostic agent (pituitary disorders); Hypogonadotropic hypogonadism; Veterinary medicine ( ... endometrial thinning agent); Uterine fibroids; Uterine hemorrhage. Implant. 1989. 400,000 ...
Autophagy
... increases the number of cancer cells killed by antineoplastic drugs.[80] ... cannabisin B possesses considerable antiproliferative activity and that it may be utilised as a promising chemopreventive agent ...
Bleomycin
Intracellular chemotherapeutic agents / antineoplastic agents (L01). SPs/MIs. (M phase). Block microtubule assembly. *Vinca ...
Belotecan
Intracellular chemotherapeutic agents / antineoplastic agents (L01). SPs/MIs. (M phase). Block microtubule assembly. *Vinca ... This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.. *v ...
Antiemetic
Cannabinoids are used in patients with cachexia, cytotoxic nausea, and vomiting, or who are unresponsive to other agents. These ...
Nilotinib
Targeted cancer therapy / antineoplastic agents (L01). CI monoclonal antibodies ("-mab"). Receptor tyrosine kinase. *ErbB: HER1 ...
Analgesic
Psychotropic agents[edit]. Other psychotropic analgesic agents include ketamine (an NMDA receptor antagonist), clonidine and ... Unselective agents Aceclofenac. Comes in betadex salt and free acid forms; practically insoluble in water, soluble in many ... Other agents directly potentiate the effects of analgesics, such as using hydroxyzine, promethazine, carisoprodol, or ... When choosing analgesics, the severity and response to other medication determines the choice of agent; the World Health ...
Stimulant
It may be used as a nasal/sinus decongestant, as a stimulant,[119] or as a wakefulness-promoting agent.[120] ... Tashkin, D. P. (1 March 2001). "Airway effects of marijuana, cocaine, and other inhaled illicit agents". Current Opinion in ... and anorectic agent.[112] It is commonly used in prescription and over-the-counter cough and cold preparations. In veterinary ... "Phenylisopropylamine stimulants: amphetamine-related agents". In Lemke TL, Williams DA, Roche VF, Zito W (eds.). Foye's ...
Romidepsin
Intracellular chemotherapeutic agents / antineoplastic agents (L01). SPs/MIs. (M phase). Block microtubule assembly. *Vinca ... Romidepsin, also known as Istodax, is an anticancer agent used in cutaneous T-cell lymphoma (CTCL) and other peripheral T-cell ...
Decongestant
List of agents[edit]. Adrenaline releasing agents[edit]. Main article: Norepinephrine releasing agent ... 3 List of agents *3.1 Adrenaline releasing agents *3.1.1 Common or widely marketed ... since these agents lose effectiveness after a few days. ...
Alkylation
This mechanism of toxicity is relevant to the function of anti-cancer drugs in the form of alkylating antineoplastic agents. ... Nucleophilic alkylating agentsEdit. Nucleophilic alkylating agents deliver the equivalent of an alkyl anion (carbanion). The ... Electrophilic alkylating agentsEdit. Electrophilic alkylating agents deliver the equivalent of an alkyl cation. Alkyl halides ... Alkylation is accomplished with the class of drugs called alkylating antineoplastic agents. ...
Teniposide
Cragg, Gordon M.; Newman, David J. (2005). "Plants as a source of anti-cancer agents". Journal of Ethnopharmacology. 100 (1-2 ... in combination with other antineoplastic drugs.[3] In Europe, it is also approved for the treatment of Hodgkin's lymphoma, ... Teniposide, when used with other chemotherapeutic agents for the treatment of ALL, results in severe bone marrow suppression. ...
Cancer
Chemotherapy is the treatment of cancer with one or more cytotoxic anti-neoplastic drugs (chemotherapeutic agents) as part of a ... Hormones are important agents in sex-related cancers, such as cancer of the breast, endometrium, prostate, ovary and testis and ... Physical agents. Some substances cause cancer primarily through their physical, rather than chemical, effects.[63] A prominent ... Agents (e.g. viruses) and events (e.g. mutations) that cause or facilitate genetic changes in cells destined to become cancer. ...
Chlorambucil
Intracellular chemotherapeutic agents / antineoplastic agents (L01). SPs/MIs. (M phase). Block microtubule assembly. *Vinca ... Additionally, these agent can be administered orally, a significant advantage. Chlorambucil was first synthesized by Everett et ... In the 1950s, aromatic mustards like chlorambucil were introduced as less toxic alkylating agents than the aliphatic nitrogen ... Like many alkylating agents, chlorambucil has been associated with the development of other forms of cancer. ...
Drug discovery
One class of these agents are bryostatin-like compounds, under investigation as anti-cancer therapy.[citation needed] ... For certain therapy areas, such as antimicrobials, antineoplastics, antihypertensive and anti-inflammatory drugs, the numbers ... Artemisinin, an antimalarial agent from sweet wormtree Artemisia annua, used in Chinese medicine since 200BC is one drug used ... The elucidation of the chemical structure is critical to avoid the re-discovery of a chemical agent that is already known for ...
Carcinogen
Alkylating antineoplastic agents (e.g. mechlorethamine). *Other alkylating agents (e.g. dimethyl sulfate) ... Genotoxins include chemical agents like N-nitroso-N-methylurea (NMU) or non-chemical agents such as ultraviolet light and ... Occupational carcinogens are agents that pose a risk of cancer in several specific work-locations:. Carcinogen. Associated ... Group 4: the agent (mixture) is probably not carcinogenic to humans.. Globally Harmonized SystemEdit. The Globally Harmonized ...
Ribociclib
Intracellular chemotherapeutic agents / antineoplastic agents (L01). SPs/MIs. (M phase). Block microtubule assembly. *Vinca ... Utilizing ribociclib in combination with other agents has been shown to reduce the development of resistance to these agents.[3 ...
Cladribine
Intracellular chemotherapeutic agents / antineoplastic agents (L01). SPs/MIs. (M phase). Block microtubule assembly. *Vinca ... As a purine analog, it is a synthetic chemotherapy agent that targets lymphocytes and selectively suppresses the immune system ... It used, often in combination with other cytotoxic agents, to treat various kinds of histiocytosis, including Erdheim-Chester ...
Antifungal
"Dermatotherapeutic Agents". Ullmann's Encyclopedia of Industrial Chemistry (7th ed.). 2007. doi:10.1002/14356007.a08_301.pub2. ... Kyriakidis I, Tragiannidis A, Munchen S, Groll AH (February 2017). "Clinical hepatotoxicity associated with antifungal agents ... "The cost effectiveness of testing for onychomycosis versus empiric treatment of onychodystrophies with oral antifungal agents ... "Current and emerging azole antifungal agents". Clinical Microbiology Reviews. 12 (1): 40-79. PMC 88906. PMID 9880474 ...
Intercalation (biochemistry)
Intracellular chemotherapeutic agents / antineoplastic agents (L01). SPs/MIs. (M phase). Block microtubule assembly. *Vinca ... Richards, A. D.; Rodgers, A. (2007). "Synthetic metallomolecules as agents for the control of DNA structure". Chemical Society ... Development and Action of Anticancer Agents. 18. Berlin: de Gruyter GmbH. pp. 387-435. doi:10.1515/9783110470734-020.. ...
WHO Model List of Essential Medicines
8 Immunomodulators and antineoplastics *8.1 Immunomodulators for non-malignant disease. *8.2 Antineoplastics and supportive ... Lipid-lowering agents[edit]. *Simvastatin[note 72]. Dermatological medicines (topical)[edit]. Antifungal medicines[edit]. * ... Immunomodulators and antineoplastics[edit]. Immunomodulators for non-malignant disease[edit]. *Adalimumabα[note 59] ... Diagnostic agents[edit]. *Tuberculin, purified protein derivative (PPD). Sera and immunoglobulins[edit]. *Antivenom ...
Proton-pump inhibitor
Within the class of medications, there is no clear evidence that one agent works better than another.[1][2] ... In British Columbia, Canada the cost of the PPIs varies significantly from 0.20 CAD to 2.38 CAD per dose while all agents in ... The cost between different agents varies significantly.[1] ...
Diuretic
The term "calcium-sparing diuretic" is sometimes used to identify agents that result in a relatively low rate of excretion of ... Alternatively, an antidiuretic, such as vasopressin (antidiuretic hormone), is an agent or drug which reduces the excretion of ... Diuretics increase the urine volume and dilute doping agents and their metabolites. Another use is to rapidly lose weight to ... "The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and ...
Prednisone
"Antineoplastic Agents, Hormonal". Medical Subject Headings. U.S. National Library of Medicine. 2009. Retrieved 11 November 2010 ...
Antineoplastic Agents: Hazardous Drug Exposures in Healthcare | NIOSH | CDC
The adverse health effects associated with antineoplastic agents (cancer chemotherapy drugs, cytotoxic drugs) in cancer ... In addition to acute or short-term effects related to treatment with antineoplastic agents, there are a number of long-term or ... The very nature of antineoplastic agents make them harmful to healthy cells and tissues as well as the cancerous cells. For ... The increased use of antineoplastic agents in veterinary oncology also puts these workers at risk for exposure to these drugs. ...
Glioblastoma Multiforme Medication: Antineoplastic agents, Anticonvulsants, Corticosteroids
Antineoplastic agents. Class Summary. Although the optimal chemotherapeutic regimen for glioblastoma is not yet defined, ... First-line agent in patients with partial and tonic-clonic seizures. Serum levels should be checked and should be approximately ... Oral alkylating agent converted to MTIC at physiologic pH; 100% bioavailable; approximately 35% crosses the blood-brain barrier ... These agents reduce edema around the tumor, frequently leading to symptomatic and objective improvement. ...
Astrocytoma Medication: Anticonvulsants, Corticosteroids, Antineoplastic Agent, Alkylating Agent
Antineoplastic Agent, Alkylating Agent. Class Summary. These agents inhibit cell growth and proliferation. ... Oral alkylating agent converted to MTIC at physiologic pH; 100% bioavailable; approximately 35% crosses the blood-brain barrier ... These agents prevent seizure recurrence and terminate clinical and electrical seizure activity. ... which can interfere with antineoplastic therapy. Steroid therapy, usually combined with a gastroprotectant, is initiated for ...
Oral Antineoplastic Agents: Assessing the Delay in Care
... Brandi Anders,1 Alexandra Shillingburg,2 and Michael Newton2,3 ... A median of 8 days elapsed between when the prescription for a first-time fill of a new oral antineoplastic agent was written ... Patients 18 years of age and older, who received a new prescription (first-time fill) for an oral antineoplastic agent, were ... The study was undertaken to determine the length of time between when a prescription for an oral antineoplastic agent is ...
List of antineoplastic agents - Wikipedia
Anti - Neoplastic Agents Market Emerging Trends || Leading
Neoplastic Agents Market Emerging Trends ,, Leading Players are Roche, Novartis, Celgene - published on openPR.com ... This study provides Anti - Neoplastic Agents sales, revenue, and market share for each player covered in this report for a ... The Anti - Neoplastic Agents Market report provides a detailed analysis of the global market size, regional and country-level ... Anti - Neoplastic Agents Market Emerging Trends ,, Leading Players are Roche, Novartis, Celgene. 03-31-2020 06:48 AM CET , ...
Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents: A Systematic Review
E. Syrigou, N. Makrilia, I. Koti, M. W. Saif, and K. N. Syrigos, "Hypersensitivity reactions to antineoplastic agents: an ... E. Syrigou, K. Syrigos, and M. W. Saif, "Hypersensitivity reactions to oxaliplatin and other antineoplastic agents," Current ... Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents: A Systematic Review. Nektaria Makrilia,1 Ekaterini ... Substituting with a Different Platinum Agent. Substituting one platinum agent with another without additional desensitization ...
Cell-cycle nonspecific antineoplastic agents - Wikipedia
Cell-cycle nonspecific antineoplastic agents (CCNS) refer to a class of pharmaceuticals that act as antitumor agents at all or ... Alkylating antineoplastic agent and anthracyclins are two examples. "Chemotherapy: The Basics". OncoLink. Archived from the ... "Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration--time product". Cancer ...
Search Results - 'Antineoplastic Agents therapeutic use.'
MedlinePlus - Search Results for: Antineoplastic Agents
that is in a class of medications called antineoplastic agents. It works by slowing or stopping the growth ... ... is in a class of medications called antifolate antineoplastic agents. It works by blocking the action of a ... ... Mitotane is in a class of medications called antineoplastic agents. It works by slowing growth or reducing the ... ... Bortezomib is in a class of medications called antineoplastic agents. It works by killing cancer cells. ...
What is the dermatologic preoperative evaluation and management of antineoplastic and immunosuppressive agents?
Alkylating agents, antimetabolites, and antibiotics have all been considered inhibitors of wound healing. Ac... more ... Many antineoplastic and immunosuppressive agents have been thought to retard wound healing. ... Many antineoplastic and immunosuppressive agents have been thought to retard wound healing. Alkylating agents, antimetabolites ... However, the use of immunosuppressive or antineoplastic agents may predispose the patient to an even greater risk of infection ...
Search of: LENALIDOMIDE AND Antineoplastic Agents - Results on Map - ClinicalTrials.gov
Hints: Click on a [map] link to show a map of that region. Click on a [studies] link to search within your current results for studies in that region. Use the back button to return to this list and try another region. Studies with no locations are not included in the counts or on the map. Studies with multiple locations are included in each region containing locations ...
Clinical Trials Using Antineoplastic Agent Combination SM-88 - National Cancer Institute
Antineoplastic Agents, Phytogenic - DrugBank
Antineoplastic Agents, Phytogenic. Accession Number. DBCAT000717. Description. Agents obtained from higher plants that have ... A taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary ... A cytotoxic agent used for the removal of soft genital (venereal) warts (condylomata acuminata).. ... A topical agent used for the treatment of external genital warts and perianal warts. ...
Antineoplastic Agents, Hormonal - DrugBank
Anti-Neoplastic Agents Manufacturing Market Forecast 2025
... and specific anti-neoplastic agents (2020-2025 Outlook)-Manufacturing & Markets Report. Equipment Type: Anti-neoplastic agents ... 2019 Global Forecast for Anti-neoplastic agents, including radioactive isotopes, ... Equipment Type: Anti-neoplastic agents, including radioactive isotopes, and specific antineoplastic. agents. Industry: ... The 2019 Global Forecast for Anti-neoplastic agents, including radioactive isotopes, and specific anti-neoplastic agents (2020- ...
Antineoplastic Agents - Merck Veterinary Manual
Merck & Co., Inc., Kenilworth, NJ, USA is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world. The Merck Veterinary Manual was first published in 1955 as a service to the community. The legacy of this great resource continues as the Merck Veterinary Manual in the US and Canada and the MSD Manual outside of North America.. ...
Search of: 'Ovarian Germ Cell Cancer' | 'Antineoplastic Agents, Phytogenic' - List Results - ClinicalTrials.gov
Enhanced immune system activation after treatment with novel antineoplastic platinum agents. - PubMed - NCBI
Antineoplastic agent | definition of antineoplastic agent by Medical dictionary
What is antineoplastic agent? Meaning of antineoplastic agent medical term. What does antineoplastic agent mean? ... Looking for online definition of antineoplastic agent in the Medical Dictionary? antineoplastic agent explanation free. ... antineoplastic agent. antineoplastic agent,. n a drug that prevents the development, maturation, or spread of neoplastic cells. ... Prevalence of antineoplastic agent use was estimated from the literature.. Occupational exposures to antineoplastic drugs and ...
Picoplatin, antineoplastic agent (CAS 181630-15-9) (ab142453) | Abcam
Cisplatin, antineoplastic agent (CAS 15663-27-1) (ab141398) | Abcam
Which medications in the drug class Antineoplastic agents are used in the treatment of Pancreatic Cancer?
Antineoplastic agentsThese agents inhibit cell growth and proliferation. They are used for chemotherapy.Gemcitabine (Gemzar)A ... Antineoplastic agents. These agents inhibit cell growth and proliferation. They are used for chemotherapy. ... Which medications in the drug class Antineoplastic agents are used in the treatment of Pancreatic Cancer?. Updated: Jan 10, ... This agent is pharmacologically classified as a human epidermal growth factor receptor type 1/epidermal growth factor receptor ...
The 2020-2025 World Outlook for Anti-Neoplastic Pharmaceutical Agents
This study covers the world outlook for anti-neoplastic pharmaceutical agents across more than 190 countries. For each year ... Anti-neoplastic pharmaceutical agents is specifically defined as follows:. 3254121176 Anti-neoplastic agents, including ... In order to estimate the latent demand for anti-neoplastic pharmaceutical agents on a worldwide basis, I used a multi-stage ... Based on the aggregate view of anti-neoplastic pharmaceutical agents as defined above, data were then collected for as many ...
Medline ®
Abstract for Reference
121 of 'Pulmonary toxicity associated with antineoplastic therapy:...
Alkylating Antineoplastic Agents
Summary Report | CureHunter
A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to ... Antineoplastic; Antineoplastic Alkylating Agents; Antineoplastic Drugs, Alkylating; Antineoplastics, Alkylating; Antineoplastic ... Alkylating Antineoplastic Agents. Subscribe to New Research on Alkylating Antineoplastic Agents A class of drugs that differs ... Antineoplastic Agents, Alkylating; Alkylating Antineoplastic Drugs; Alkylating Antineoplastics; Alkylating Drugs, ...
Results for: Subject:Antineoplastic Agents | EthicShare Community
Antineoplastics agents
Antineoplastic Agents for sale - China Antineoplastic Agents suppliers
Antineoplastic Agents products for sale from more than 13836 Antineoplastic Agents manufacturers and Antineoplastic Agents ... Antineoplastic Agents. All Antineoplastic Agents wholesalers & Antineoplastic Agents manufacturers come from members. We ... doesnt provide Antineoplastic Agents products or service, please contact them directly and verify their companies info ...
DrugsAssociated with oral antineoplastic agentsSafe handling of antineoplast2018Chemotherapeutic agentsPotential antineoplastic activityExposureToxicityAnti-neoplastic agentsCyclophosphamideTherapeuticPotent antineoplasticAntimicrobial Agents and CHormonalCisplatinChemotherapy agentsApoptosisTumorsCytostaticEtoposide2017NIOSH2016TumorImmunosuppressivePaclitaxelAntitumor agentsAnthracyclineTreatmentVeterinaryNursesDrugActivityVinblastineClinical trialsPancreatic cancerCardiotoxicCytotoxic agents
Drugs39
- The adverse health effects associated with antineoplastic agents (cancer chemotherapy drugs, cytotoxic drugs) in cancer patients and some non-cancer patients treated with these drugs are well documented. (cdc.gov)
- Pharmacists who prepare these drugs or nurses who may prepare and/or administer them are the two occupational groups who have the highest potential exposure to antineoplastic agents. (cdc.gov)
- The increased use of antineoplastic agents in veterinary oncology also puts these workers at risk for exposure to these drugs. (cdc.gov)
- Additionally, analytical methods have been used to document worker exposure to antineoplastic agents by measuring these drugs and/or their metabolites in the urine of health care workers. (cdc.gov)
- Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings, 2004 pdf icon (DHHS (NIOSH) Publication No. 2004-165) . (cdc.gov)
- Currently, there are more than sixty oral antineoplastic drugs available, 22 of which are oral kinase inhibitors that have gained worldwide approval since 2001 [ 1 ]. (hindawi.com)
- Experts now estimate that more than one-quarter of the 400 antineoplastic agents now under development are planned as oral drugs [ 2 - 4 ]. (hindawi.com)
- Several surveys have shown that most patients prefer oral antineoplastic drugs to intravenous treatment primarily for the convenience of a home-based therapy and ease of use [ 2 , 3 ]. (hindawi.com)
- A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. (curehunter.com)
- According to a new study funded by the National Institute for Occupational Safety and Health (NIOSH) and published online in the Journal of Occupational and Environmental Hygiene, researchers have found that healthcare workers do not always follow recommended safe handling practices for the administration of antineoplastic drugs in healthcare settings . (oncologynurseadvisor.com)
- Healthcare workers do not always follow recommended safe handling practices for antineoplastic drugs. (oncologynurseadvisor.com)
- A new National Institute for Occupational Safety and Health (NIOSH) study, published online in the Journal of Occupational and Environmental Hygiene, found that recommended safe handling practices for workers who administer antineoplastic drugs in healthcare settings are not always followed. (oncologynurseadvisor.com)
- This paper presents findings on current administrative and engineering control practices, personal protective equipment (PPE), and barriers to using recommended PPE during administration of antineoplastic drugs by nearly 2,100 oncology nurses and other healthcare personnel who completed a module addressing antineoplastic drug administration. (oncologynurseadvisor.com)
- Valley Cottage, NY -- ( SBWIRE ) -- 02/25/2019 -- Anti-neoplastic pharmaceutical agents are the drugs which prevent or inhibit the maturation and proliferation of neoplasms and thus helps in the management of cancer. (sbwire.com)
- Thus, growing demand for anti-neoplastic pharmaceutical agents has captured the attention of pharmaceutical companies to enter into anti-neoplastic pharmaceutical agents market and develop more efficient drugs against several cancer conditions. (sbwire.com)
- Geographically, North America followed by Europe dominates the global anti-neoplastic pharmaceutical agents owing high prevalence of cancer cases and increasing demand of drugs for cancer treatment. (sbwire.com)
- Most antineoplastic drugs target what activity? (brainscape.com)
- The aim of this study was to review the literature regarding the external contamination of commercial vials by antineoplastic drugs. (bmj.com)
- Detoxifying agents for antineoplastic treatment and its peer markets - Wireless Health , Tissue adhesives , Iron chelating agents , Next Generation Sequencing (NGS) , Other therapeutic products , Chromatography , Nerve depressants , Chromatography Instruments , Drugs for treatment of hypercalcemia and 11 other markets - adds up to total All other therapeutic products market. (micromarketmonitor.com)
- Antineoplastic agents are basically drugs used in cancer treatment. (workoutforfatloss.com)
- Antineoplastic agents are drugs used in cancer treatment that can inhibit the growth and the development of a neoplasm, or the abnormal mass of tissues. (workoutforfatloss.com)
- Antineoplastic drugs are specifically used to destroy or inhibit the growth of neoplasms. (workoutforfatloss.com)
- Apart from the cancer patients receiving antineoplastic agents, nurses, hospital technicians, as well as pharmacists handling these drugs may experience the aforementioned side effects due to long-term exposure. (workoutforfatloss.com)
- Anthracyclines are effective antineoplastic drugs that are widely used in clinical practice. (usda.gov)
- Antineoplastic agents are used in cytotoxic drugs and cancer chemotherapy drugs. (hoffmannworkcomp.com)
- The pharmacists who prepare the drugs using these agents can suffer due to contact with them. (hoffmannworkcomp.com)
- The workers who handle the packaging and shipping of the drugs may accidentally come into contact with the agents and expose themselves to the harmful effect of the antineoplastic agents. (hoffmannworkcomp.com)
- This page includes surveys conducted by researchers and organizations on handling procedures used when working with antineoplastic drugs. (unt.edu)
- The sample may have been biased as many patients receiving treatments frequently associated with drug-induced hyperpigmentation, such as antineoplastic drugs, are diagnosed and treated by other specialties, such as oncologists. (jabfm.org)
- A great number of antineoplastic drugs (ANPDs) are used globally in cancer treatment. (asstsas.com)
- Cavallo D., Ursini CL, Omodeo-Salé E, Iavicoli S. Micronucleus induction and FISH analysis in buccal cells and lymphocytes of nurses administering antineoplastic drugs. (unt.edu)
- Using PPE to prevent occupational exposure to antineoplastic and other hazardous drugs. (unt.edu)
- Fransman W, Huizer D, Tuerk J. Inhalation and dermal exposure t eight antineoplastic drugs in an industrial laundry facility. (unt.edu)
- Fransman W, Peelen S, Hilhorst S, Roeleveld N, Heederik D, Kromhout H. A pooled analysis to study trends in exposure to antineoplastic drugs among nurses. (unt.edu)
- Fransman W, Roeleveld N, Peelen S, Kort de W, Kromhout H, Heedrik D. Nurses with dermal exposure to antineoplastic drugs Reproductive Outcomes. (unt.edu)
- Environmental and biologocal monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. (unt.edu)
- Ikeda K, Yagi Y, Tkegami M, Lu Y, Morimoto K, Kurokawa N. Efforts to ensure safety of hospital pharmacy personnel occupationally exposed to antineoplastic drugs during a preparation task. (unt.edu)
- Many alkylating agents are pro-drugs which are converted into an active metabolite in the body. (greek.doctor)
- Drugs of this group are related to mustard gas, a chemical warfare agent. (greek.doctor)
Associated with oral antineoplastic agents1
- Due to the increased costs associated with oral antineoplastic agents, many pharmacy benefit plans have implemented cost-containment mechanisms [ 3 , 7 ]. (hindawi.com)
Safe handling of antineoplast3
- Principles of safe handling of antineoplastic agents. (edcan.org.au)
- This page includes guideline for the safe handling of antineoplastic agents from professional organizations, government agencies and international groups. (unt.edu)
- This page lists reviews of the literature published on the topic of safe handling of antineoplastic agents which provide background information on the topic. (unt.edu)
20181
- Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.The global Anti - Neoplastic Agents market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. (amarketforecast.com)
Chemotherapeutic agents2
- The effect of pretreatment with anguidine on the cytotoxicity of subsequently administered various chemotherapeutic agents, hyperthermia, and radiation was investigated. (aacrjournals.org)
- Rabusertib binds to and inhibits the activity of chk2, which may prevent the repair of DNA caused by DNA-damaging agents, thus potentiating the antitumor efficacies of various chemotherapeutic agents. (wikimd.org)
Potential antineoplastic activity6
- R-(-)-gossypol acetic acid - The orally bioavailable solvate of the R-(-) enantiomer of gossypol and acetic acid with potential antineoplastic activity. (wikimd.org)
- Racemetyrosine/methoxsalen/phenytoin/sirolimus sm-88 - A combination agent containing racemetyrosine, methoxsalen, phenytoin and sirolimus, with potential antineoplastic activity. (wikimd.org)
- Radgocitabine - An analogue of the nucleoside deoxycytidine with potential antineoplastic activity. (wikimd.org)
- Nab-paclitaxel/rituximab-coated nanoparticle ar160 - A formulation composed of nanoparticle albumin-bound (nab) paclitaxel, which is an albumin-stabilized nanoparticle containing the natural taxane paclitaxel, non-covalently coated with rituximab, a recombinant chimeric murine/human antibody directed against the CD20 antigen found on B-lymphocytes, with potential antineoplastic activity. (wikimd.org)
- Nadofaragene firadenovec - A replication-deficient recombinant adenovirus encoding human interferon alpha-2b with potential antineoplastic activity. (wikimd.org)
- Nadofaragene firadenovec/syn3 - A non-replicating recombinant adenovirus type 5 (Ad5)-vector encoding the gene for interferon alpha-2b (IFN alpha-2b) and the gene transfer enhancement agent Syn 3, with potential antineoplastic activity. (wikimd.org)
Exposure13
- The purpose of this brochure is to make you aware of the adverse health effects of antineoplastic agents, describe how you can be exposed to these agents, and provide and identify control methods and work practices to prevent or reduce your exposure to antineoplastic agents. (cdc.gov)
- However, for the health care workers who are exposed to antineoplastic agents as part of their work practice, precautions should be taken to eliminate or reduce exposure as much as possible. (cdc.gov)
- A number of studies have documented environmental and worker exposure to the antineoplastic agents. (cdc.gov)
- Healthcare workers and oncology nurses should be fully aware of the hazards associated with not following these guidelines and the precautionary measures that can be used to minimize exposure to antineoplastic agents. (oncologynurseadvisor.com)
- These agents are considered cytotoxins, mutagens, and carcinogens, and hence, their proper handling is important to reduce occupational exposure. (workoutforfatloss.com)
- Occupational exposure to antineoplastic agents can have a dangerous impact on those who handle them. (hoffmannworkcomp.com)
- This increases the exposure of the workers to these agents. (hoffmannworkcomp.com)
- Research has shown that exposure to antineoplastic agents is harmful for the environment and the workers. (hoffmannworkcomp.com)
- They are likely to suffer the most due to exposure to these antineoplastic agents. (hoffmannworkcomp.com)
- If you have suffered health problems due to exposure to antineoplastic agents in the workplace, you should discuss your rights with a St. Louis worker injury lawyer . (hoffmannworkcomp.com)
- This page contains articles published within the past three years on all topics related to occupational exposure to antineoplastic agents. (unt.edu)
- The acute effects associated with exposure to antineoplastic agents, such as skin rashes, allergic-type reactions, hair loss and others, are included in the publications listed in this page. (unt.edu)
- Important exposure controls for protection against antineoplastic agents: Highlights for oncology health care workers. (asstsas.com)
Toxicity7
- Hypersensitivity to a chemotherapeutic agent is defined as an unforeseen reaction whose signs and symptoms cannot be explained by the known toxicity of the drug [ 29 ]. (hindawi.com)
- We report a case of pulmonary toxicity associated with the relatively new antineoplastic agent topotecan. (thefreedictionary.com)
- The selective cytotoxicity displayed by these conjugates towards tested cancer cells with non-toxicity against normal human VERO cells indicated their potential for further antineoplastic drug development. (eurekaselect.com)
- Thus, it appears that the two opposite effects of anguidine modification of cell kill by cytotoxic agents (protection and potentiation) come about by two different mechanisms, with cell cycle arrest underlying cytoprotection and the mechanism of synergistic toxicity remaining obscure. (aacrjournals.org)
- However, the use of cisplatin as an anticancer agent is limited due to toxicity and resistance problems. (uwc.ac.za)
- Carmofur is one of the masked compounds of 5-FU, which was modified for more potent antineoplastic activity and less toxicity. (invivochem.com)
- Combining multiple antitumor agents increases the cytotoxicity against cancer cells without necessarily increasing the general toxicity. (greek.doctor)
Anti-neoplastic agents31
- A new research study has been presented by UpMarketResearch.com offering a comprehensive analysis on the Global Anti - Neoplastic Agents Market where user can benefit from the complete market research report with all the required useful information about this market. (openpr.com)
- This segmentation sheds light on the sales of the Anti - Neoplastic Agents on regional- and country-level. (openpr.com)
- The competitive landscape chapter of the global market report provides key information about market players such as company overview, total revenue (financials), market potential, global presence, Anti - Neoplastic Agents sales and revenue generated, market share, prices, production sites and facilities, products offered, and strategies adopted. (openpr.com)
- This study provides Anti - Neoplastic Agents sales, revenue, and market share for each player covered in this report for a period between 2016 and 2020. (openpr.com)
- Our report helps readers decipher the current and future constraints in the Anti - Neoplastic Agents Market, and help them formulate optimum business strategies to maximize growth in the market. (openpr.com)
- The 2019 Global Forecast for Anti-neoplastic agents, including radioactive isotopes, and specific anti-neoplastic agents (2020-2025 Outlook)-Manufacturing & Markets Report, published by Barnes Reports, contains timely and accurate market statistics and forecasts on the market for over 140 countries. (bccresearch.com)
- Anti-neoplastic agents are used prominently as a first line therapy for cancer treatment as well as in combination with surgery or radiation therapy. (cyberessays.com)
- Plenty of anti-neoplastic agents are available commercially for the treatment of different types of cancers including Oncotrex, Gleevec, Neosar, Cytarine, Leukeran etc. (cyberessays.com)
- Factors such as growing incidence of cancer across the globe and demand for cost-effective treatment options are believed to play crucial role for the growth of global anti-neoplastic agents market. (cyberessays.com)
- Anti-neoplastic agents do not get stabilized in one part of the body, however they travel through body and help in destruction of cancerous cells. (sbwire.com)
- In this report, the global Anti-Neoplastic Agents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. (qyresearchreports.com)
- In the recent times, the global market for Global anti neoplastic agents market research report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global anti neoplastic agents market research report 2017 across the world. (qyresearchreports.com)
- Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global anti neoplastic agents market research report 2017 production processes, which is also reflecting positively on the growth of this market. (qyresearchreports.com)
- The research report on the Global anti neoplastic agents market research report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. (qyresearchreports.com)
- Using a number of effective assessment tools, such as porter's five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global anti neoplastic agents market research report 2017 and provides deep insights into the future prospects of this market. (qyresearchreports.com)
- The study begins with a detailed overview of the market for Global anti neoplastic agents market research report 2017, including the definition, classification, and industry chain structure of Global anti neoplastic agents market research report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. (qyresearchreports.com)
- With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global anti neoplastic agents market research report 2017. (qyresearchreports.com)
- Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global anti neoplastic agents market research report 2017 in details. (qyresearchreports.com)
- It provides in-depth information on the development trends and the policies and regulations, concerning Global anti neoplastic agents market research report 2017, implemented in each of the geographical segments. (qyresearchreports.com)
- The predominant applications of the Global anti neoplastic agents market research report 2017 have also been discussed at length in this research study. (qyresearchreports.com)
- With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global anti neoplastic agents market research report 2017 at present and are projected to remain doing so over the forecast period. (qyresearchreports.com)
- According to GlobalData's report, ' Diabetic Retinopathy: Global Drug Forecast and Market Analysis to 2029 ', combined sales of two anti-neoplastic agents: ziv-aflibercept and imatinib mesylate, are projected to climb from $19m in 2024 to $75m in 2026. (globaldata.com)
- The size of the Global Anti-neoplastic Agents Market is estimated to grow at a CAGR of 8.3% from 2019 to 2024. (marketdataforecast.com)
- Anti-neoplastic Agents are the first line of treatment for cancer. (marketdataforecast.com)
- However, the high manufacturing costs of anti-neoplastic agents is the major factor hampering the Anti-neoplastic Agents Market growth. (marketdataforecast.com)
- This research report on the Global Anti-neoplastic Agents Market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024. (marketdataforecast.com)
- The Global Anti-neoplastic Agents market was dominated by North America closely followed Europe. (marketdataforecast.com)
- This report focuses on Anti - Neoplastic Agents volume and value at global level, regional level and company level. (amarketforecast.com)
- From a global perspective, this report represents overall Anti - Neoplastic Agents market size by analyzing historical data and future prospect.Regionally, this report categorizes the production, apparent consumption, export and import of Anti - Neoplastic Agents in North America, Europe, China, Japan, Southeast Asia and India. (amarketforecast.com)
- For each manufacturer covered, this report analyzes their Anti - Neoplastic Agents manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market. (amarketforecast.com)
- These studies demonstrated the feasibility of employing a PLGA-based microparticulate system as an effective biodegradable, injectable, depot-forming therapeutic system for long-term administration of anti-neoplastic agents. (elsevier.com)
Cyclophosphamide3
- Among the antineoplastic agents employed in this project, cyclophosphamide, etoposide, vinblastine and vincristine were potently inhibited the CYP3A4, 2C19 and 2D6 mediated oxidative drug metabolism determined by the typical substrates corresponding to each CYP enzyme. (nii.ac.jp)
- Alkylating agents like cyclophosphamide alkylates and damages DNA. (greek.doctor)
- Cyclophosphamide is the most commonly used alkylating agent. (greek.doctor)
Therapeutic2
- Antineoplastic Agents therapeutic use. (illinois.edu)
- In the Anatomical Therapeutic Chemical Classification System , alkylating agents are classified under L01A. (chemeurope.com)
Potent antineoplastic1
- Two trace (0.7 and 2.2×10 -7 % yields) potent antineoplastic macrocyclic lactones termed spongistatins 8 (2a) and 9 (2b) have been isolated from the African marine sponge Spirastrella spinispirulifera and found to be very potent inhibitors of glutamate-induced tubulin polymerization. (elsevier.com)
Antimicrobial Agents and C1
- Current chemotherapy and infectious disease : proceedings of the 11th International Congress of Chemotherapy and the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, Massachusetts, 1-5 October 1979 / editors, John D. Nelson, Carlo Grassi. (who.int)
Hormonal4
- A synthetic estrogen that has been used as a hormonal antineoplastic agent. (drugbank.com)
- Antineoplastic Agents, Hormonal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (jefferson.edu)
- This graph shows the total number of publications written about "Antineoplastic Agents, Hormonal" by people in this website by year, and whether "Antineoplastic Agents, Hormonal" was a major or minor topic of these publications. (jefferson.edu)
- Below are the most recent publications written about "Antineoplastic Agents, Hormonal" by people in Profiles. (jefferson.edu)
Cisplatin2
- On the other hand, alkylating agents such as cisplatin, cis- [PtCl2 (NH3) 2] have been widely used as antineoplastic agents for a wide variety of cancers including testicular, ovarian, neck and head cancers, amongst others. (uwc.ac.za)
- On the other hand the newly synthesized palladium complexes also need further evaluation to see if they can be used as anticancer agents that can overcome the problems associated with cisplatin. (uwc.ac.za)
Chemotherapy agents6
- The aim of this paper is to provide recent data concerning hypersensitivity reactions to platinum-containing chemotherapy agents. (hindawi.com)
- Background Currently, oral antineoplastic agents (OAA) represent approximately 40% of all chemotherapy agents. (ovid.com)
- Most chemotherapy agents interfere with what carcinogenesis phase? (brainscape.com)
- They are specially designed chemotherapy agents that can attack the rapidly proliferating cancerous cells. (workoutforfatloss.com)
- These chemotherapy agents were first used in 1940. (workoutforfatloss.com)
- These chemotherapy agents can attack the healthy cells of the body, while destroying the abnormal cancerous cells. (workoutforfatloss.com)
Apoptosis3
- Antitumor agent, displays a spectrum of antineoplastic activity including inhibition of DNA replication and transcription, and the induction of apoptosis. (abcam.com)
- Cordycepin, a Natural Antineoplastic Agent, Induces Apoptosis of Breast Cancer Cells via Caspase-dependent Pathways. (sigmaaldrich.com)
- Taurolidine has significant antineoplastic activity against MM in vitro and in vivo , in part, due to tumor cell apoptosis. (aacrjournals.org)
Tumors5
- Metastatic pure choriocarcinoma is treated with the same multi-agent chemotherapy regimens used in nonseminomatous germ cell tumors (NSGCTs), which are discussed in a separate article (see Nonseminomatous Testicular Tumors ). (medscape.com)
- Platinum agents are also effective in pediatric tumors [ 16 , 17 ]. (hindawi.com)
- Antineoplastic agents that are used to treat hormone-sensitive tumors. (drugbank.ca)
- Anti-Neoplastic pharmaceutical agents are used in combination with surgery, immunotherapy, radiotherapy, hormone therapy, targeted therapy for many solid tumors, especially metastatic. (sbwire.com)
- It also prevents the tumors from developing resistance to individual agents. (greek.doctor)
Cytostatic1
- Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (drugbank.ca)
Etoposide3
- Here, we report that the antineoplastic agents, daunorubicin hydrochloride, etoposide, and vincristine sulfate inhibited the ability of 1,25(OH) 2 D 3 to cause the accumulation of mRNA for kidney 25-hydroxyvitamin D 3 24-hydroxylase (CYP24), an enzyme which catabolizes this hormone. (aacrjournals.org)
- Our data show that daunorubicin hydrochloride, etoposide, and vincristine sulfate, three well-characterized antineoplastic agents, caused the accumulation of 1,25(OH) 2 D 3 in kidney cells. (aacrjournals.org)
- Etoposide is an antineoplastic agent used for treating lung cancer, testicular cancer, breast cancer, pediatric cancers, and lymphomas. (springer.com)
20172
- A new research document with title 'Global and Chinese Antineoplastic Agent Industry , 2017 Market Research Report' covering detailed analysis, Competitive landscape, forecast and strategies. (beforeitsnews.com)
- The report then estimates 2017-2022 market development trends of Antineoplastic Agent industry. (beforeitsnews.com)
NIOSH1
- Research conducted by the NIOSH shows that the antineoplastic agents are harmful for the cancerous cells but they harm the healthy cells and tissues also. (hoffmannworkcomp.com)
20161
- 2016 Global Antineoplastic and Immunomodulating Agents Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Antineoplastic and Immunomodulating Agents industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). (bigmarketresearch.com)
Tumor1
- This leads to cell death of the CD20-expressing tumor cells that were targeted by this agent. (wikimd.org)
Immunosuppressive4
- What is the dermatologic preoperative evaluation and management of antineoplastic and immunosuppressive agents? (medscape.com)
- Many antineoplastic and immunosuppressive agents have been thought to retard wound healing. (medscape.com)
- However, the use of immunosuppressive or antineoplastic agents may predispose the patient to an even greater risk of infection, and physicians may consider the use of prophylactic antibiotics. (medscape.com)
- What is the definition of Antineoplastic and immunosuppressive agents? (dictionary.net)
Paclitaxel3
- Paclitaxel is a taxoid antineoplastic agent indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast cancer. (pharmacycode.com)
- Paclitaxel is a novel antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilizes microtubules by preventing depolymerization. (pharmacycode.com)
- Nab-paclitaxel - A Cremophor EL-free, albumin-stabilized nanoparticle formulation of the natural taxane paclitaxel with antineoplastic activity. (wikimd.org)
Antitumor agents2
- Cell-cycle nonspecific antineoplastic agents (CCNS) refer to a class of pharmaceuticals that act as antitumor agents at all or any phases of the cell cycle. (wikipedia.org)
- To investigate whether both anguidine-induced potentiation and protection of cells by different antitumor agents were due to its induction of complete suspension of cycle traverse, experiments were also conducted with plateau-phase cultures. (aacrjournals.org)
Anthracycline2
- For example, adriamycin, one of the most active antineoplastic agents, is a glycosidic anthracycline antibiotic that is a fermentation product of the fungus, Streptomyces peucetius var. (justia.com)
- N,n-dibenzyl daunomycin - The N-alkylated analogue of the anthracycline antineoplastic antibiotic daunomycin. (wikimd.org)
Treatment18
- For cancer patients with a life-threatening disease, there is certainly a great benefit to treatment with these agents. (cdc.gov)
- In addition to acute or short-term effects related to treatment with antineoplastic agents, there are a number of long-term or chronic effects that have been identified in patients. (cdc.gov)
- For the past several decades, cancer treatment has entailed primarily intravenous delivery of antineoplastic agents. (hindawi.com)
- The use of oral antineoplastic agents for cancer treatment removes the routine and continuous monitoring that was included with intravenous treatment. (hindawi.com)
- A topical agent used for the treatment of external genital warts and perianal warts. (drugbank.ca)
- A taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer. (drugbank.ca)
- Docetaxel Injection is an antineoplastic agent intended for the treatment of breast cancer, non-small cell lung cancer ("NSCLC"), prostate cancer, gastric adenocarcinoma, and head and neck cancer. (thefreedictionary.com)
- Cladribine is an antineoplastic agent that has been approved for the treatment of active hairy cell leukemia. (thefreedictionary.com)
- SAN DIEGO -- The antineoplastic agent letrozole is a promising alternative to clomiphene citrate as a frontline treatment for ovulation induction, results of a small prospective study suggest. (thefreedictionary.com)
- Which medications in the drug class Antineoplastic agents are used in the treatment of Pancreatic Cancer? (medscape.com)
- The data shed light on the possibility of cordycepin being a safe agent for breast cancer treatment. (sigmaaldrich.com)
- A range of packaging for antineoplastic agents for the treatment of cancers. (recollection.com.au)
- Detoxifying agents for antineoplastic treatment can be segmented by Submarkets, Ingredients and Applications. (micromarketmonitor.com)
- which of Detoxifying agents for antineoplastic treatment markets are doing well and which are not? (micromarketmonitor.com)
- This report provides market sizing and forecast for the Detoxifying agents for antineoplastic treatment market. (micromarketmonitor.com)
- Role of antineoplastic agents in the treatment and palliation of cancer. (edcan.org.au)
- The nurses who administer the treatment like chemotherapy may be exposed to the negative influence of the agents. (hoffmannworkcomp.com)
- Study results offering them as palliative therapy options in cancer or as anticancer agents with high levels of cytotoxicity brought a new approach to combine cancer treatment protocols with these products. (usda.gov)
Veterinary1
- Antineoplastic agents are also used extensively in veterinary oncology . (hoffmannworkcomp.com)
Nurses2
- s Closed System for Antineoplastic Agent Administration," was conducted by a team of nurses at the Abramson Cancer Center of the Hospital of the University of Pennsylvania, a National Cancer Institute-designated comprehensive cancer center with more than 55,000 doses of chemotherapy delivered per year. (thefreedictionary.com)
- Of 2,100 oncology nurses and other healthcare personnel, 80% do not wear two pairs of chemotherapy gloves and 15% do not even wear a single pair during the administration of antineoplastic agents to patients. (oncologynurseadvisor.com)
Drug5
- With the average cost of a new oral antineoplastic drug in 2012 approximating $10,000, paying for medications can be a significant out-of-pocket expense and burden for patients. (hindawi.com)
- In this study had clarify the possibility of the drug-drug interaction with the concomitant administration among the commonly ad antineoplastic agents in routine chemotherapy. (nii.ac.jp)
- Drug repurposing against COVID-19: focus on anticancer agents. (coviki.org)
- Like other alkylating agents, chlorambucil is potentially mutagenic, teratogenic, and carcinogenic, and an increased incidence of acute leukaemias and other secondary malignancies has been reported in patients who have received the drug. (pocketdrugguide.com)
- Presently, there are about 50 antineoplastic agents that have been approved by the Food and Drug Administration of the United States. (workoutforfatloss.com)
Activity5
- Calcitriol or 1,25-dihydroxyvitamin D 3 [1,25(OH) 2 D 3 ] and analogues have received much interest as anticancer agents because the secosteroid hormone has shown antitumor activity ( 1 - 3 ). (aacrjournals.org)
- Interestingly, antineoplastic agents are known to stimulate the activity of MAP kinases ( 12 - 15 ). (aacrjournals.org)
- Publications] Hua Li, Norimitsu Kurata, Yuki Nishimura, Mariko Iwase, Eiji Uchida and Hajime Yasuhara: 'The effect of antineoplastic agent vinblastine and vincristine on CYP3A4, CYP2C19 and CYP2D6 activity in human liver microsomes'Xenobiotica. (nii.ac.jp)
- These agents prevent seizure recurrence and terminate clinical and electrical seizure activity. (medscape.com)
- Na17.A2 Peptide vaccine - A peptide cancer vaccine comprised of human leukocyte antigen HLA-A2-restricted peptide derived from a metastatic melanoma cell line of patient NA17, with potential immunomodulating and antineoplastic activity. (wikimd.org)
Vinblastine1
- Additional agents in some regimens or for salvage include vinblastine and ifosfamide. (medscape.com)
Clinical trials2
- The clinical trials on this list are studying Antineoplastic Agent Combination SM-88. (cancer.gov)
- Several new antineoplastic agents are in clinical trials such as Oncofetal Ag (phase 1), Panobinostat (Phase 2), Volasertib (phase 2), Bortezomib (phase 4) etc. which are expected to launch in next 5-10 years. (cyberessays.com)
Pancreatic cancer1
- A human epidermal growth factor receptor type 1/epidermal growth factor receptor (HER-1/EGFR) tyrosine kinase inhibitor used in combination with the antineoplastic agent gemcitabine for advanced pancreatic cancer in patients who have not yet received chemotherapy. (thefreedictionary.com)
Cardiotoxic1
- This agent is less cardiotoxic than daunomycin. (wikimd.org)
Cytotoxic agents2
- These agents are also known as cytotoxic agents. (sbwire.com)
- Most cytotoxic agents act upon process of cell growth and division: potent and potentially dangerous. (vetstream.com)